Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Suraiya Rasheed

Suraiya Rasheed

University of Southern California, USA

Jenny Wang

Jenny Wang

University of New South Wales, Australia

Manal H Al Khanbashi

Manal H Al Khanbashi

Higher College of Technology Oman

Atsushi Kaneda

Atsushi Kaneda

Chiba University Japan

Mariam Matar

Mariam Matar

Founder and Chairperson, UAE Genetic Disease Association UAE

Bengt-Åke Anderson

Bengt-Åke Anderson

Department of Clinical and Experimental Medicine, Linköping University Sweden

Wancai Yang

Wancai Yang

Institute of Precision Medicine, Jining Medical University China

Arnab Nayak

Arnab Nayak

Institute for Molecular and Cell Physiology, Hannover Medical School Germany

Epitranscriptomics 2018

About Conference

ME Conferences Graciously invites all the members and attendees from all over the world to attend “International Conference on Epigenetics and Epitranscriptomics" during November 26-27, 2018 at Helsinki, Finland with the Theme: The Evolving Landscape of Epigenetic Research which embraces prompt Keynote Presentations, Oral talks, Poster Presentations, Workshop, Symposia and Demonstrations.

Epitranscriptomics 2018 is a relatively new field in the world of genetics and a brand new look at the RNA field of Genetics and Molecular Biology which studies the structure and function of genes at a molecular level. The consider of chromosomes and quality expression of a life form can provide knowledge into heredity, hereditary mutation, and changes. This is valuable to study the developmental biology and treating the hereditary diseases. Epitranscriptomics 2018 revolves around the theme: “The Evolving Landscape of Epigenetic Research" which is all about simplifying the complex phenomenon behind Epigenetic mechanism & protein expression. The capacity to get a large picture of sickness transcriptomes & how it gives a clear understanding of the principal genome which is changed over into the valuable quality calming classification, assurance and individualized treatment.

Why to Attend?

Epitranscriptomics Conference is a novel discourse to join together in general recognized scholastics in the field of Hereditary qualities and atomic science Analysts, Open prosperity specialists, Researchers, Scholastic analysts, Industry masters, Researchers to exchange almost condition of the Investigate and Advancement.

Point of this gathering is to fortify new views for treatment that will be valuable over the range of Epitranscriptomics. Importantly, mutations in core-regulators of the epitranscriptomes are causative in many human diseases or congenital disorders. It Is Also a Great Opportunity to Intermingle with Members across the World and Form Molecular level, Related Associations and Societies.

Target Audience:

Our organization takes immense pleasure in welcoming,

·         Scientists

·         Epigenetics, Genetics and Oncology Researchers

·         Human Genetics/ Epigenetics/Cancer Associations and Society

·         Molecular Biologists

·         Business delegates

·         Directors, Board Members, Presidents, Vice Presidents

·         Cell Biologists

·         CEO's and R&D Heads from Industries

·         Business Entrepreneurs and Industrialists

·         Human Genetics Researchers

·         Pharmacists

·         Drug Manufacturing Companies and Industries

·         Laboratory Technicians and Diagnostic Company





Track 1. Epigenetics

The study of heritable changes in gene expression that occur without a change in DNA sequence (i.e., an adjustment in phenotype without an adjustment in genotype) is called Epigenetics. In all living organisms, epigenetic controls are essential for normal development and they become misdirected in cancer cells and other human disease syndromes. Epigenetic modifications can marked such as the manner in which cells terminally differentiate to transpire as skin cells, liver cells, brain cells, etc. The epigenetic alterations having more damaging effects that can result in diseases like cancers.

There are two primary and interrelated epigenetic mechanisms: DNA methylation and covalent modification of histones.

Track 2. Epigenetic Mechanisms

The epigenetic component is to allude complex intelligent between the mapping of genome and the environment that are included in advancement and separation in higher living beings. The heritable changes that are not due to changes in DNA sequence, but it will happened DNA methylation and histone adjustment. The changes of DNA availability and chromatin structure, subsequently directing designs of quality expression. These forms are basic to ordinary improvement and separation of person cell ancestries in the grown-up life form. They can be reformed by exogenous effects; as such can contribute to the result of natural alterations of phenotype or pathophenotype.


Track 3. Genomes and Epigenomes                         

Epigenomes are made up of some chemical compounds and proteins which will attribute some genes and DNA that monitoring the production of proteins in a particular cell. The epigenomes have many alterations to the genome and some specialized cell that makes protein.

The chemical modifications of epigenomes to the DNA and DNA-associated proteins in the cell, which alter gene expression, and are heritable. The variations occur as a tissue development and differentiation that can be altered in response to environmental exposures and diseases. The epigenome has immediate applications for diagnostics. Changes to the epigenome can result in changes to the structure of chromatin and changes to the function of the genome.


Track 4. Computational Epigenetics

The current field of epigenetics includes a few mechanisms, including DNA methylation, histone modification, and microRNAs.DNA methylation is a covalent modification, heritable by somatic cells after cell division. Epigenetic modifications influence phenotype through heritable regulation of gene expression. The environment-induced epigenetic defects are known to play a major role in cancer and ageing.


Track 5. Epigenetics and Environmental Origins of Cancer

The Identification of epigenetic occasions discharged by particular natural and presence stressors, and these discoveries proceed to amplify our understanding of the mechanism of carcinogenesis, particularly those linked to risk-factor exposures and aging. In addition, important insights into epigenetic mechanisms and associated exposure risk factors have had a functional impact of specific human cancers. Environmental contaminants are linked to impacts on human health and consequences of combustion to contaminating trace metals and residual organic compounds used in daily life.


Track 6. Epigenetics in Cardiovascular Disease

The DNA methylation, post translational histone modifications, and microRNA regulation are key mechanisms underlying healthy cardiovascular function as well as heart disease and its precursors. There is increasing evidence for the involvement of epigenetics in human disease such as cancer, inflammatory disease and CV disease. Other chronic diseases are also susceptible to epigenetic modification such as metabolic diseases including obesity, metabolic syndrome, and diabetes mellitus. There is much evidence for the modification of epigenetics by nutrition and exercise. Epigenetics are also involved in cardiovascular risk factors such as smoking, diabetes and hypertension. Gene expression regulation through the interplay of DNA methylation and histone modifications is well-established, although the knowledge about the function of epigenetic signatures in cardiovascular disease is still largely unexplored


Track 7. Pharmacogenomics & Personalized Medicine

The practices of personalized medicine are to maximize the therapeutic efficiency of likelihood and to minimize the risk of drug toxicity for an individual patient. Pharmacogenomics is the study of the genome in drug response. The genetic disorder occurrence is quite rare in population; some might be hereditary while the others are caused by mutations. Disease-specific epigenetic signatures such as DNA methylation, hydroxymethylation, and non-coding RNAs are now being utilized clinically for prognostics and diagnostics, while an expanding collection of genetically aberrant, abnormally expressed or chromatin-interacting epigenetic enzymes are positioned as promising targets for therapeutic intervention.


Track 8. Nutritional Epigenetics

Nutritional epigenetics is to clarify the effects of nutrition on gene expression. It serves as a site to specify and illustrate new concepts of metabolism and food emergent. Nutritional epigenetics has been observed as an attractive implement to prevent pediatric developmental diseases and cancer as well as to delay aging-associated processes. In recent years, epigenetics has become an emerging issue in a broad range of diseases such as type 2 diabetes mellitus, obesity, inflammation, and neurocognitive disorders.

Nutritional genomics pursues to expand the use of foods to reach human genetic potential, while reducing the risk of diseases.


Track 9. Epigenetic Diseases – Clinical Applications

It is the application of molecular biology techniques to detecting alterations in DNA methylation or histone modification to analyze the study of disorders characterized by heritable defects in the expression of a gene or genome. While epigenetic changes are required for normal development and health, they can also be responsible for some disease states. Disturbing any of the three frameworks that contribute to epigenetic modifications can cause unusual actuation or quieting of qualities. Such disturbances have been related with cancer, disorders including chromosomal dangers, mental hindrance and immune responses. Numerous maladies counting cancer, heart infection, diabetes and mental sicknesses are impacted by epigenetic instruments.

Track 10. Current Case studies in Epigenetics and Epitranscriptomics

It is the knowledge of epigenetics, combined with rise of technologies such as CRISPR/Cas9 gene editing and next-generation sequencing. In recent years, it permits us to superior recognize the interaction between epigenetic alter, quality direction, and human diseases, and will lead to the improvement of unused approaches for atomic determination and focused on molecular medicines over the clinical range. Recent technical advances such as ChIP-on-ChIP and ChIP-seq have started to convert epigenetic research. The advance knowledge in the field is to understand the basic biology and human diseases, the catalyzing adoption of epigenetics or epitranscriptomics methods. Finally, the advancement of current approaches, coupled with new technologies, will allow for the development of new therapies and therapeutic targets for human diseases associated with deficient RNA modification.


Track 11. Plant Epigenetics

Epigenetic component makes a difference to ensure the plant cells from the action of parasitic groupings such as transposable components, this defense can complicate the hereditary designing prepare through transcriptional quality silencing. The frequently occurring changes in plants which incorporates heritable or metastable changes causing varieties in epigenetic status. Hence, heritable epigenetic varieties as well as hereditary variety have the potential to drive common varieties in plants. Climate alter is without a doubt one of the most prominent dangers confronting both plants and creatures alike. With rising temperatures and irregular climate designs, dry spells have gotten to be a distant as well typical event worldwide.


Track 12. Translational Epigenetics

The emerging promise of translational epigenetics is highlighted in a range of stimulating clinical experiments underway on epigenetic pathways which offer new therapeutic approaches to cancer. Epigenetic modifications such as DNA methylation, histone modifications and nucleosome remodeling have been found to be diagnostic hallmarks in a range of human tumors. The pathways which are regulated (or mis regulated) via histone modifications, DNA methylation and other epigenetic marks are being investigated as potential targets of such epi-drugs.

Track 13. Stem cells and Epigenetics 

The epigenetic basis of stem cell differentiation arises from the need to maintain gene expression patterns in both stem/progenitor cells and their differentiated progenies. As a stem cell differentiates, genes associated with self-renewal are down-regulated, while lineage-specific genes are activated. It then follows that the inherited epigenetic marks deposited on those genes must be reversible. Chromatin modifying enzymes with opposing activities play a key role in the dynamic regulation of epigenetic marks. Defining the signaling pathways of these enzymes induced by differentiation-inducing cues is critical to understanding the mechanisms underlying stem cell differentiation. Furthermore, non-coding RNAs, especially microRNAs, provide additional layers for regulation of gene expression during cell fate specification. These multiple layers of regulation allow for rapid transition of proliferating stem cells into their differentiated progenies.


Track 14. Epigenetic Drug Discovery

Immune-mediated infections are clinically heterogeneous but they share hereditary and pathogenic components. These infections may create from the transaction of hereditary variables and natural or way of life variables. A developing understanding of how epigenetic instruments control quality expression designs and cell work has been helped by the advancement of small-molecule inhibitors that target these forms. These chemical instruments have made a difference to uncover the significance of epigenetics in directing cell destiny choices amid resistant reactions and have too highlighted the potential for focusing on epigenetic components for the treatment of aggravation and immune-mediated illnesses. The epigenetic dysregulation in cancers as well as encounters to epigenetic drug discovery with emerging biology and novel classes of drug targets.


Track 15. Epitranscriptomics

Epitranscriptomics can be defined as a functionally relevant change to the transcriptome that do not involve a change in the ribonucleotide sequence. The epitranscriptome, therefore, is defined as the study of posttranscriptional changes with vigour in both protein-coding and non-coding RNAs reveals a new complexity in gene regulation. Thus leading to 'Epitranscriptomics', organized with bioinformatics approaches and RNA modifications .There are a few sorts of RNA alterations that affect quality expression. These adjustments happen to all sorts of cellular RNA counting, but not constrained to, ribosomal RNA (rRNA), Transfer ribonucleic acid RNA (tRNA), Messenger RNA (mRNA), and little atomic RNA (snRNA). The most collective and well-understood mRNA alteration at show is the N6-Methyladenosine (m6A), which has been inspected to happen an normal of three times in each mRNA methylation.


Track 16. RNA editing in Epitranscriptomics

The transcriptome is widely and dynamically regulated by a network of RNA modifying factors. RNA editing enzymes APOBEC (apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like) and ADAR (adenosine deaminase, RNA-specific) irreversibly recode primary RNA sequences, whereas newly described methylases (writers) and de-methylases (erasers) dynamically alter RNA molecules in response to environmental conditions. RNA modifications can affect RNA splicing, nuclear-cytoplasmic transport, translation, and regulation of gene expression by RNA interference. In addition, tRNA base modifications,processing, and regulated cleavage have been shown to alter global patterns of mRNA translation in response to cellular stress pathways .The epitranscriptomics, involves  in the enzymatic pathways that regulate these activities in cancer stem cell initiation and progression.


Track 17. Epitranscriptomics for Biomedical Discovery

Epitranscriptomics is the complete description and explication of chemical modifications of nucleotides found inside all classes of RNA that do not involve a change in the ribonucleotide sequence. the concepts of nucleotide modification, summarize transcriptome‐wide RNA modification gene mapping techniques, highlight recent studies exploring the functions of RNA modifications and their association to diseases.

The Epigenetic research contains the application of bioinformatics methods and the RNA modifications to resolve the epigenetic problems, as well as biomedical data analysis and academic modeling in epigenetics. This involves the effects of histone and DNA CpG island methylation. .A few techniques available to determine the global occurrence of a particular RNA modification. Thus, there is a need for the development of more high‐throughput techniques to characterize the full spectra of RNA modifications. It is also important to pursue the comprehensive identification and characterization of the enzymes responsible for RNA modification since several of these enzymes have been shown to play important roles in development and diseases.


Track 18. Epigenetics Biomarkers

Epigenetic biomarkers defined as the modifications of the genome with preserved DNA sequence. DNA methylation measurement in cell, it may also be useful in improving early detection by measuring tumor DNA released into the blood. Molecular biomarkers are used routinely in a clinical setting to assess the medical state of patients and in several other medical contexts, including clinical trial endpoints, pharmaceutical development, and basic science research. The clinical validation of epigenetic biomarkers to allow the accurate prediction of the outcome of cancer patients and their potential chemosensitivity to current pharmacological treatments. A clinical example of a biomarker is plasma glucose.


Track 19. Clinical studies of Epigenetics and Epitranscriptomics

Epigenetic changes, including DNA methylation, histone modifications, RNA epigenetics and nucleosome altering, are important for gene transcription, but such modifications do not conversion the coding sequence of the gene.  So epigenetic changes have been trusted into the lead of new drug discoveries. DNA utilize in cancer patients and hereditary or epigenetic interchanges particular to tumor DNA have been cautious in patients known with diverse sorts of cancer. Later inquire about proposes that our count calories and way of life can alter the expression of our qualities. This happens by altering epigenetic marks on best of our DNA without really making any changes to the fundamental hereditary disorders. For illustration, blueberries were found to epigenetically diminish DNA harm and drinking green tea may turn a few qualities on or off in women.

Related Associations or Societies:


American Society of Human Genetics (ASHG), National Society of Genetic Counsellors (NSGC), American College of Medical Genetics (ACMG), American Board of Genetic Counselling (ABGC), American Board of Medical Genetics (ABMG), Nation Coalition for Health Education in Genetics (NCHPEG), International Society of Nurses in Genetics (ISONG), Council of Regional Networks (CORN) discontinuedCanadian College of Medical GeneticistsCollege Canadian de Généticiens Médicaux (CCMG), Canadian Collaborative Group for Cancer Genetics (CCGCG), European Genetics Foundation (EGF)Clinical Molecular Genetics Society (CMGS) United KingdomThe American Public Health AssociationNational Society of Genetic CounselorsInternational Mammalian Genome Society, British Society of Genetic MedicineInternational Federation of Human Genetics SocietiesGenetics society of America


European Society Of Human GeneticsAmerican Society of Human Genetics  ,German Genetics SocietyInternational Society of Genetic GenealogyThe American Society of HaematologyASGCT  American Society of Gene & Cell TherapyInternational Society of Genetic GenealogyAustrian Society for Human GeneticsBelgian Society for Human GeneticsCzech Society of Medical GeneticsDanish Society of Medical Genetics

Asia-Pacific and Middle East

East Asian Union of Human Genetics Societies, Association of Chinese Geneticists in AmericaHong Kong Society of Medical GeneticsJapan Society of Human GeneticsGenetics Society of Korea (GSK), Korean Society of Human GeneticsGenetics Society of VietnamTurkish Association of Medical GeneticsJapan Society of Gene TherapyHuman Genetics Society of Australasia (HGSA), Australian Society of Genetic Counsellors ,Genetic Society of Australia (GSA),American Human Geneticists of Indian Subcontinent OriginIndian Society of Human GeneticsNational Laboratory for the Genetics of Israeli PopulationsIsraeli Society of Medical GeneticistsMiddle East Genetics Association

Related Conferences:
Epigenetics Conferences | Genetics Congress | Biotechnology Meetings | 
11th Regenerative Medicine Congress July 19-20, 2018, Dubai, UAE;

3rd Molecular Diagnostics Conference April 19-20, 2018, Dubai, UAE;

3rd Stem Cell Conference, July 19-20, 2018, Dubai, UAE;
4th synthetic biology Conference June11-12, Rome, Italy;
2nd Cell Metabolism Summit September 19-20, 2018, Philadelphia, USA;
6th Integrative Biology Conference May 21-23, 2018, Barcelona, Spain; 
Advanced Diabetes Conference, April 27-28, 2018, Abu Dhabi, UAE;
Paediatrics Conference, Molecular Genetics Conferences | Molecular Biology Congress | Biotechnology Meetings
3rd Stem Cell Conference, July 19-20, 2018, Dubai, UAE; 
Rare Diseases Congress  August 27-29, 2018, Dubai, UAE;
3rdMolecular Diagnostics Conference April 19-20, 2018, Dubai, UAE;
11th Regenerative Medicine Congress July 19-20, 2018, Dubai, UAE;
2nd Cell therapy Summit November 09-10, 2018, Atlanta, USA;
20th biotechnology Congress March 05-07, 2018, London, UK; 
Organ Transplantation congress August 24-25, 2018, Tokyo, Japan;
4th synthetic biology Conference June11-12, Rome, Italy;
9th Tissue Science Conference July 13-14, 2018, Sydney, Australia;  
Pediatrics Conference, Jan-29-Feb01, 2018, Dubai, UAE;
World Biotechnology Congress, June 25-27, 2018, Dubai, UAE; 
World Vaccines Congress, June28-30, 2018, Dubai, UAE; 
Advanced Diabetes Conference, April 27-28, 2018, Abu Dhabi, UAE;
Biotechnology Conference, March 05-07, 2018, Dubai, UAE


Market Analysis

Scope: The Scope of the conference is to gather all the Physicians, Researchers, Business Delegates and Scientists to approach and deliver all the attendees about the latest scientific advancements on the particular sphere of influence. This Epigenetics and Epitranscriptomics Conference is the premier event focusing on understanding in individual and organizational behaviour and decision-making related to genetics and molecular biology, biotechnology, pharmaceuticals, medicals and academia.


Importance:  Conference on Epitranscriptomics is a much celebrated conference which basically deals with the latest research and developments in the sphere of genetics and molecular biology .This Conference will give a culminate stage to all the Worldwide blend of driving Investigate Researchers, and Researchers accomplished significance in their field of think about, investigate academicians from the colleges and investigate teach, mechanical inquire about experts and trade partners along with Ph.D. Understudies to come and illuminate all the participants around the most recent logical progressions on the individual circle.



The conference discusses the latest research outcomes and technological advancements in the field of genetics and molecular biology.

•           Scientists

•           Epigenetics, Genetics and Oncology Researchers

•           Human Genetics/ Epigenetics/Cancer Associations and Society

•           Molecular Biologists

•           Business delegates

•           Directors, Board Members, Presidents, Vice Presidents

•           Cell Biologists

•           CEO's and R&D Heads from Industries

•           Business Entrepreneurs and Industrialists

•           Human Genetics Researchers

•           Pharmacists

•           Drug Manufacturing Companies and Industries

•           Laboratory Technicians and Diagnostic Companies


                Industry               60%

                Academia            35%

                Others                  05%


Today’s Market Study of Epitranscriptomics research in USA | Europe | Middle East | Asia Pacific

Asia pacific: The Europe genetic testing market is valued at USD 1.20 billion in 2016, and is projected to reach USD 1.6 billion by 2021, growing with a compound annual growth rate (CAGR) of 8.2% during the forecast period, 2016-2020.

USA:  The USA Genetics market is poised to reach USD 19.99 Billion by 2020, growing at a CAGR of 9.9% during the forecast period of 2015 to 2020.

Europe: The global Epigenetic value on market was estimated $419.4 million in 2013 and is expected to grow at a CAGR of 13.9% in the next five years.

Middle East: The global gene expression analysis market is projected to reach USD 5.30 Billion by 2020 from USD 3.39 Billion in 2015, at a CAGR of 9.3% from 2015 to 2020. The primary growth appliance in this region is China, which is expected to record a growth rate of 12.5% in the forecast period.


The falling sequencing expenses and time increase in research activities to identify and progress inhibitors/drugs for various diseases, funding for epigenetics research, and rising the preventation of cancer are the major factors driving the progression of this market.

The global market for Epigenetic Testing is forecast to reach US$2.4 billion by 2018. Increasing knowledge about the potential benefits in Epigenetic testing is one of the prime reasons for the growth of the genetic analysis. Developments in the genetic modifications space, aging population and a consequent rise in the number of genetic diseases, and increasing incidence of cancer cases are the other factors impelling growth in the genetic testing market.

Global Epigenetics Market, by Research Areas

·         Developmental Biology

·         Drug Discovery

·         Oncology

·         Other Epigenetics Research Areas

Genetic and Epigenetic risk Factors:

Epidemiological and clinical studies have shown that children exposed to adverse experiences are at increased risk for the development of depression, anxiety disorders, and posttraumatic stress disorder (PTSD). A history of child abuse and maltreatment increases the likelihood of being subsequently exposed to traumatic events or of developing PTSD as an adult. The brain is highly plastic during early life and encodes acquired information into lasting memories that normally subserve adaptation. Epigenetic phenomena are increasingly recognized as important drivers of disease risk, like diabetic Kidney Disease and various cancers.



Why it’s in Helsinki,??

Helsinki is the capital of Finland, vibrant seaside of attractive islands and prodigious green parks. Helsinki’s is been awarded with City of Design status by UNESCO. The population of 1.4 million makes it the most populous metropolis and urban area in Finland with important political, educational, financial, cultural and research centre. The capital of Finland is filled with lively events all year round. Design Scene, Architectural Innovations, Finnish Flavours, Natural Environment add colours to Helsinki.

Scientists in Finland are working on making stem cells as key to youth. Stem cell research is widely recognised and funded in European Countries where researchers doing great work on stem cell and regenerative medicine.  In fact, ensuing the principle that stem cell research provides vast prospective to create new treatments for several serious diseases such as diabetes and heart disease. The location of the Helsinki Airport is the neighbouring city of Vantaa, which has frequent service to

many destinations in Europe and Asia. Helsinki was the World Design Capital for 2012.



University of Oxford

University of Washington

Stanford University

University of Tokyo

University of Cambridge

Icahn School of Medicine at Mount Sinai

University of Queensland Australia

McGill University

University of British Columbia

Aix-Marseille Universities

Karolinska Institute

University of Helsinki

London School of Hygiene & Tropical Medicine

University of Chicago

Top universities in Finland:

University of Helsinki

University of Tampere

Abo Akademi University

University of Oulu

University of Eastern Finland

University of Jyväskylä

Tampere University of Technology

University of Turku

Aalto University

Lappeenranta University of Technology




Past Conference Report

Epigenetics and Cancer 2017

Epigenetics and Cancer 2017 are delighted to announce the International Conference on Cancer Genetics & Epigenetics which will be held between October 26-28, 2017 at Osaka, Japan. It is our pleasure to welcome you to take part in this conference. This gathering at Osaka, Japan will continue for three days which includes prompt Keynote Presentations, Poster Presentations, E-poster, Oral talks, Symposia, Workshop, Scientific meetings and Exhibitions.

Epigenetics and Cancer 2017 is organized with the theme “From Novel therapies to Revolutionary Strategies, Diagnosis and Treatment”. This conference is comprised of many interactive sessions related to Genetics and Epigenetics which comprises a broad range from novel advancements to various strategies for diagnosis and treatment.

Goal of the conference

The central goal of this conference is to give a universal discussion for cutting edge research and inquire about  Cancer Genetics and Epigenetics. This gathering gives "the central point" for individuals to introduce their examination and research thoughts. Purpose of this event is to strengthen new perspectives for treatment that will be significant over the scope of Epigenetics and Cancer.

Why to attend?

Epigenetics and Cancer 2017  Conference is a novel discussion to unite overall recognized scholastics in the field of Oncology, Epigenetics and Genetics Researchers, Public wellbeing experts, Scientists, Academic researchers, Industry specialists, Scholars to to exchange about state of the Research and Development. The arranging group assembles eminent speakers covering the most recent advances in the field, fusing differing qualities in each sense. We like wise incorporate talks on most recent methodologies for concentrating these biological inquiries. We encourage multidisciplinary approach as well. A Unique Opportunity for Advertisers and Sponsors at this International event.

 Target Audience

•           Scientists

•           Professors and Students from Academia

•           Epigenetics, Genetics and Oncology Researchers

•           Human Genetics/ Epigenetics/Cancer Associations and Societies

•           Business Entrepreneurs & Allied health professionals.

•           Training Institutes

•           Software developing companies

•           Business delegates

•           Data Management Companies

•           Pharmaceutical Companies

•           Diagnostics Companies

•           Industrial Leaders

•           Medical Colleges

•           Molecular Biologists,

•           CEO’s, directors and R&D Heads

Epigenetics and Cancer 2017 are organized by  Conference Series Ltd  which is comprised of 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field all over the globe.

Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date November 26-27, 2018

Speaker Opportunity

Supported By

Journal of Genetic Syndromes & Gene Therapy Journal of Stem Cell Research & Therapy Journal of Cell Science & Therapy Hereditary Genetics: Current Research

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by

Media partners & Collaborators & Sponsors


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner




Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner









Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos


  • Allergic Disorders
  • Animal Cloning Epigenetics
  • Applied Genetics
  • Asthma Epigenetics
  • Autoimmunity
  • Biomarkers
  • Cancer Epigenetics
  • Cancer Immunotherapy
  • Cancer Stem Cell
  • Carcinogen Evaluation
  • Carcinogenesis
  • Cardiomyopathy
  • Chiasma
  • Chip Sequencing
  • Chromatin
  • Chromatin Architecture
  • Clinical Epigenetics
  • Congenital
  • CpG Island
  • Crop Epigenetics
  • Cytogenetics
  • Developmental Epigenetics
  • DNA Damage And Repair
  • DNA Folding
  • DNA Footprinting
  • DNA Methylation
  • DNA Repair
  • DNA Replication
  • DNA-associated Proteins
  • Drug Toxicity
  • Ecological Epigenetics
  • Epi-drugs
  • Epigenetic Aging
  • Epigenetic Gene Regulation
  • Epigenetic Reversibility
  • Epigenetics
  • Epigenetics Inhibitors
  • Epigenome
  • Epitranscriptomics
  • Gene Expression
  • Gene Imprinting
  • Gene Mapping
  • Gene Ontology
  • Gene Pool
  • Gene Therapy
  • Genetic Engineering
  • Genetic Recombination
  • Genetic Testing
  • Genetic Variation
  • Genomic Imprinting
  • Genomic Instability
  • Germ Cell
  • Hematopoiesis
  • Heredity
  • Histone Modification
  • Human Genetics
  • Human Imprinting Disorders
  • Human Infectious Diseases
  • Human Tumors
  • Hybridization
  • Hybridization And Heterosis
  • Hypertension
  • Immune Diseases
  • Inflammation
  • Maternal Gene
  • Melanoma
  • Messenger RNA
  • Metabolomics
  • Molecular Biomarkers
  • MRNA Alteration
  • MRNA Capping
  • Mutagenesis
  • Mutation Research
  • Nano-biology
  • Neurocognitive Disorders
  • Neurodevelopmental Disorders
  • Obesity
  • Ovarian Cancer
  • Parental Gene
  • Pharmacogenomics
  • Pharmacokinetics
  • Phenotypic Variation
  • Psuedourylation
  • Psychiatric Disorders
  • Psychiatric Genetics
  • Pulmonary Heart Disease
  • Replication
  • Rheumatic Heart Disease
  • Ribosomal RNA
  • RNA Modifications
  • RNA Post-Transcriptional Modifications
  • RNA Processing
  • RNA Splicing
  • RNAediting
  • Single-cell Epigenetics
  • Small Nuclear RNA
  • Small-molecule Inhibitor
  • SnRNAs
  • Splicing And Polyadenylation
  • Stem Cells
  • Toxicology
  • Transcription
  • Transcriptome
  • Transfer RNA
  • Translational Epigenetics